Crossmark

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12885-017-3312-7

Published Online: 2017-05-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Johnson, Alison C.

Matias, Margarida

Boyle, Helen

Escudier, Bernard

Molinier, Alicia

Laguerre, Brigitte

Helissey, Carole

Brachet, Pierre-Emmanuel

Dugué, Audrey Emmanuelle

Mourey, Loic

Coquan, Elodie

Joly, Florence